Our Emergency Department (ED) researchers found that a protocol allowing nurses to give steroids to asthmatic patients on arrival to the ED improves patients faster and shortens their ED visit.
Our genetics research team discovered the genes responsible for rare disorders such as Floating Harbor syndrome, Joubert syndrome, Weaver syndrome, and Hajdu Cheney syndrome.
Prolactin is shown to improve survival in mice with Spinal Muscular Atrophy and provides hope for a possible treatment for this condition that is the most common genetic killer of infants.
Small amounts of a sugar water solution given by mouth can effectively reduce pain in babies less than one year of age during painful events such as needles and blood tests.
Our scientists found a way to trick resistant cancer cells into committing suicide following oncolytic virus therapy.
Our healthy active living and obesity researchers, in partnership with the Canadian Society for Exercise Physiology and ParticipACTION, developed the world’s first evidence informed sedentary behaviour guidelines for children (aged 5-11 years) and youth (aged 12-17 years). These provide important and timely recommendations on activity levels in children based on scientific evidence.
Children with a rare bone disorder (osteogenesis imperfecta) who were treated with oral alendronate had better bone mineral density results after two years of treatment, but did not have improved pain, mobility or fewer fractures. Our researchers concluded that oral alendronate should not replace the current standard of treatment for osteogenesis imperfecta.